204 related articles for article (PubMed ID: 25609808)
1. Structure of the extracellular domain of matrix protein 2 of influenza A virus in complex with a protective monoclonal antibody.
Cho KJ; Schepens B; Seok JH; Kim S; Roose K; Lee JH; Gallardo R; Van Hamme E; Schymkowitz J; Rousseau F; Fiers W; Saelens X; Kim KH
J Virol; 2015 Apr; 89(7):3700-11. PubMed ID: 25609808
[TBL] [Abstract][Full Text] [Related]
2. Crystal Structure of the Conserved Amino Terminus of the Extracellular Domain of Matrix Protein 2 of Influenza A Virus Gripped by an Antibody.
Cho KJ; Schepens B; Moonens K; Deng L; Fiers W; Remaut H; Saelens X
J Virol; 2016 Jan; 90(1):611-5. PubMed ID: 26468526
[TBL] [Abstract][Full Text] [Related]
3. Influenza type A virus escape mutants emerge in vivo in the presence of antibodies to the ectodomain of matrix protein 2.
Zharikova D; Mozdzanowska K; Feng J; Zhang M; Gerhard W
J Virol; 2005 Jun; 79(11):6644-54. PubMed ID: 15890902
[TBL] [Abstract][Full Text] [Related]
4. Hierarchical and Redundant Roles of Activating FcγRs in Protection against Influenza Disease by M2e-Specific IgG1 and IgG2a Antibodies.
Van den Hoecke S; Ehrhardt K; Kolpe A; El Bakkouri K; Deng L; Grootaert H; Schoonooghe S; Smet A; Bentahir M; Roose K; Schotsaert M; Schepens B; Callewaert N; Nimmerjahn F; Staeheli P; Hengel H; Saelens X
J Virol; 2017 Apr; 91(7):. PubMed ID: 28077656
[TBL] [Abstract][Full Text] [Related]
5. A lipidated form of the extracellular domain of influenza M2 protein as a self-adjuvanting vaccine candidate.
Zeng W; Tan AC; Horrocks K; Jackson DC
Vaccine; 2015 Jul; 33(30):3526-32. PubMed ID: 26049002
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies recognizing EVETPIRN epitope of influenza A virus M2 protein could protect mice from lethal influenza A virus challenge.
Liu W; Zou P; Chen YH
Immunol Lett; 2004 May; 93(2-3):131-6. PubMed ID: 15158608
[TBL] [Abstract][Full Text] [Related]
7.
Van den Hoecke S; Ballegeer M; Vrancken B; Deng L; Job ER; Roose K; Schepens B; Van Hoecke L; Lemey P; Saelens X
mBio; 2021 Aug; 12(4):e0074521. PubMed ID: 34253060
[TBL] [Abstract][Full Text] [Related]
8. Selective Engagement of FcγRIV by a M2e-Specific Single Domain Antibody Construct Protects Against Influenza A Virus Infection.
De Vlieger D; Hoffmann K; Van Molle I; Nerinckx W; Van Hoecke L; Ballegeer M; Creytens S; Remaut H; Hengel H; Schepens B; Saelens X
Front Immunol; 2019; 10():2920. PubMed ID: 31921179
[TBL] [Abstract][Full Text] [Related]
9. Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin.
Huleatt JW; Nakaar V; Desai P; Huang Y; Hewitt D; Jacobs A; Tang J; McDonald W; Song L; Evans RK; Umlauf S; Tussey L; Powell TJ
Vaccine; 2008 Jan; 26(2):201-14. PubMed ID: 18063235
[TBL] [Abstract][Full Text] [Related]
10. Matrix Protein 2 Extracellular Domain-Specific Monoclonal Antibodies Are an Effective and Potentially Universal Treatment for Influenza A.
Bimler L; Ronzulli SL; Song AY; Johnson SK; Jones CA; Kim T; Le DT; Tompkins SM; Paust S
J Virol; 2021 Mar; 95(5):. PubMed ID: 33268521
[TBL] [Abstract][Full Text] [Related]
11. Fine specificity and sequence of antibodies directed against the ectodomain of matrix protein 2 of influenza A virus.
Zhang M; Zharikova D; Mozdzanowska K; Otvos L; Gerhard W
Mol Immunol; 2006 Jul; 43(14):2195-206. PubMed ID: 16472860
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody recognizing SLLTEVET epitope of M2 protein potently inhibited the replication of influenza A viruses in MDCK cells.
Wang Y; Zhou L; Shi H; Xu H; Yao H; Xi XG; Toyoda T; Wang X; Wang T
Biochem Biophys Res Commun; 2009 Jul; 385(1):118-22. PubMed ID: 19410554
[TBL] [Abstract][Full Text] [Related]
13. The epitope recognized by a monoclonal antibody in influenza A virus M2 protein is immunogenic and confers immune protection.
Zou P; Liu W; Chen YH
Int Immunopharmacol; 2005 Apr; 5(4):631-5. PubMed ID: 15710332
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a fully human monoclonal antibody against extracellular domain of matrix protein 2 of influenza A virus.
Ozawa T; Jin A; Tajiri K; Takemoto M; Okuda T; Shiraki K; Kishi H; Muraguchi A
Antiviral Res; 2011 Sep; 91(3):283-7. PubMed ID: 21726583
[TBL] [Abstract][Full Text] [Related]
15. Bispecific T cell engaging antibody constructs targeting a universally conserved part of the viral M2 ectodomain cure and prevent influenza A virus infection.
Pendzialek J; Roose K; Smet A; Schepens B; Kufer P; Raum T; Baeuerle PA; Muenz M; Saelens X; Fiers W
Antiviral Res; 2017 May; 141():155-164. PubMed ID: 28257797
[TBL] [Abstract][Full Text] [Related]
16. Enhanced immune response induced by a potential influenza A vaccine based on branched M2e polypeptides linked to tuftsin.
Liu X; Guo J; Han S; Yao L; Chen A; Yang Q; Bo H; Xu P; Yin J; Zhang Z
Vaccine; 2012 Oct; 30(46):6527-33. PubMed ID: 22959982
[TBL] [Abstract][Full Text] [Related]
17. Protection against Influenza A Virus Challenge with M2e-Displaying Filamentous Escherichia coli Phages.
Deng L; Ibañez LI; Van den Bossche V; Roose K; Youssef SA; de Bruin A; Fiers W; Saelens X
PLoS One; 2015; 10(5):e0126650. PubMed ID: 25973787
[TBL] [Abstract][Full Text] [Related]
18. An influenza A vaccine based on tetrameric ectodomain of matrix protein 2.
De Filette M; Martens W; Roose K; Deroo T; Vervalle F; Bentahir M; Vandekerckhove J; Fiers W; Saelens X
J Biol Chem; 2008 Apr; 283(17):11382-7. PubMed ID: 18252707
[TBL] [Abstract][Full Text] [Related]
19. An H5N1-based matrix protein 2 ectodomain tetrameric peptide vaccine provides cross-protection against lethal infection with H7N9 influenza virus.
Leung HC; Chan CC; Poon VK; Zhao HJ; Cheung CY; Ng F; Huang JD; Zheng BJ
Emerg Microbes Infect; 2015 Apr; 4(4):e22. PubMed ID: 26038770
[TBL] [Abstract][Full Text] [Related]
20. Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies.
De Filette M; Martens W; Smet A; Schotsaert M; Birkett A; Londoño-Arcila P; Fiers W; Saelens X
Vaccine; 2008 Dec; 26(51):6503-7. PubMed ID: 18835315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
